Skip to main content
. Author manuscript; available in PMC: 2010 Sep 6.
Published in final edited form as: Future Oncol. 2009 Dec;5(10):1555–1584. doi: 10.2217/fon.09.121

Fig 6.

Fig 6

Pre-treatment nomogram for predicting 5-year biochemical recurrence-free probability after radical prostatectomy including pre-operative plasma levels of transforming growth factor β1 and interleukin-6 soluble receptor. Reprinted with permission from Kattan et al [100].

HHS Vulnerability Disclosure